| Rakesh K Jain, MD | |
|
7101 Jahnke Rd, Suite 550, Richmond, VA 23225 | |
| (804) 560-8880 | |
| (804) 560-9577 |
| Full Name | Rakesh K Jain |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 42 Years |
| Location | 7101 Jahnke Rd, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013992874 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centra Southside Community Hospital, Inc | Farmville, VA | Hospital |
| Bon Secours Mary Immaculate Hospital | Newport news, VA | Hospital |
| Centra Health - Lynchburg Gen Hospital | Lynchburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours Medical Group Hampton Roads Specialty Care Llc | 3173955671 | 165 |
| Centra Medical Group Llc | 4789606088 | 603 |
News Archive
Biodel Inc. announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 70th Scientific Sessions of the American Diabetes Association this month in Orlando, Florida:
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.
While all Americans will eventually die, CBS's 60 Minutes reports, it may turn some heads to find out how much the government will spend when it happens - in 2008, about $50 billion in the last two months of life. "You might think this would be an obvious thing for Congress and the president to address as they try to reform health care. But what used to be a bipartisan issue has become a politically explosive one - a perfect example of the costs that threaten to bankrupt the country and how hard it's going to be to rein them in."
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Hospital patients taking the commonly prescribed hypnotic agent zolpidem are at an increased risk for falls, which in turn significantly increase morbidity and healthcare costs, say US researchers.
› Verified 3 days ago
| Entity Name | Chippenham & Johnston-willis Hospitals, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366689747 PECOS PAC ID: 9032105010 Enrollment ID: O20040831000405 |
News Archive
Biodel Inc. announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 70th Scientific Sessions of the American Diabetes Association this month in Orlando, Florida:
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.
While all Americans will eventually die, CBS's 60 Minutes reports, it may turn some heads to find out how much the government will spend when it happens - in 2008, about $50 billion in the last two months of life. "You might think this would be an obvious thing for Congress and the president to address as they try to reform health care. But what used to be a bipartisan issue has become a politically explosive one - a perfect example of the costs that threaten to bankrupt the country and how hard it's going to be to rein them in."
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Hospital patients taking the commonly prescribed hypnotic agent zolpidem are at an increased risk for falls, which in turn significantly increase morbidity and healthcare costs, say US researchers.
› Verified 3 days ago
| Entity Name | Centra Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20051230000147 |
News Archive
Biodel Inc. announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 70th Scientific Sessions of the American Diabetes Association this month in Orlando, Florida:
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.
While all Americans will eventually die, CBS's 60 Minutes reports, it may turn some heads to find out how much the government will spend when it happens - in 2008, about $50 billion in the last two months of life. "You might think this would be an obvious thing for Congress and the president to address as they try to reform health care. But what used to be a bipartisan issue has become a politically explosive one - a perfect example of the costs that threaten to bankrupt the country and how hard it's going to be to rein them in."
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Hospital patients taking the commonly prescribed hypnotic agent zolpidem are at an increased risk for falls, which in turn significantly increase morbidity and healthcare costs, say US researchers.
› Verified 3 days ago
| Entity Name | Bon Secours Medical Group Hampton Roads Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629637475 PECOS PAC ID: 3173955671 Enrollment ID: O20191122000258 |
News Archive
Biodel Inc. announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 70th Scientific Sessions of the American Diabetes Association this month in Orlando, Florida:
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.
While all Americans will eventually die, CBS's 60 Minutes reports, it may turn some heads to find out how much the government will spend when it happens - in 2008, about $50 billion in the last two months of life. "You might think this would be an obvious thing for Congress and the president to address as they try to reform health care. But what used to be a bipartisan issue has become a politically explosive one - a perfect example of the costs that threaten to bankrupt the country and how hard it's going to be to rein them in."
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Hospital patients taking the commonly prescribed hypnotic agent zolpidem are at an increased risk for falls, which in turn significantly increase morbidity and healthcare costs, say US researchers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rakesh K Jain, MD 7101 Jahnke Rd, Suite 550, Richmond, VA 23225 Ph: (804) 560-8880 | Rakesh K Jain, MD 7101 Jahnke Rd, Suite 550, Richmond, VA 23225 Ph: (804) 560-8880 |
News Archive
Biodel Inc. announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 70th Scientific Sessions of the American Diabetes Association this month in Orlando, Florida:
Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.
While all Americans will eventually die, CBS's 60 Minutes reports, it may turn some heads to find out how much the government will spend when it happens - in 2008, about $50 billion in the last two months of life. "You might think this would be an obvious thing for Congress and the president to address as they try to reform health care. But what used to be a bipartisan issue has become a politically explosive one - a perfect example of the costs that threaten to bankrupt the country and how hard it's going to be to rein them in."
NanoViricides, Inc. announced today that March 29th, 2012 has been confirmed by the US FDA as the date for its initial meeting with the Company's scientists. This pre-IND meeting will focus on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
Hospital patients taking the commonly prescribed hypnotic agent zolpidem are at an increased risk for falls, which in turn significantly increase morbidity and healthcare costs, say US researchers.
› Verified 3 days ago
Dr. Amy Samantha May Paul, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall St, Dept. Of Internal Medicine/geriatric Medicine, Richmond, VA 23298 Phone: 804-254-3500 Fax: 804-254-1616 | |
Dr. Clifton Linwood Parker, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8300 Fulham Drive, Richmond, VA 23227 Phone: 804-264-5901 | |
Dr. Michael A Mistretta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6600 W Broad St Ste 300, Richmond, VA 23230 Phone: 804-320-4243 Fax: 804-622-0552 | |
Patricia J Sime, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 9000 Stony Point Pkwy, Richmond, VA 23235 Phone: 804-560-8921 Fax: 804-560-8992 | |
Dr. Katherine Lavan Smallwood, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6900 Forest Ave, Suite 300, Richmond, VA 23230 Phone: 804-346-1515 Fax: 804-270-2888 | |
Walid G. Abou Assi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7605 Forest Ave, Suite 109, Richmond, VA 23229 Phone: 804-285-6390 Fax: 804-285-6393 | |
Dr. Paulina Essah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 719 N 25th St, Richmond, VA 23223 Phone: 804-253-1963 Fax: 804-780-0862 |